Published in J Cardiovasc Pharmacol on January 01, 1990
Interaction between endothelin and vasodilators in the human internal mammary artery. Br J Clin Pharmacol (1994) 0.85
A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat Res (1998) 1.74
Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine. J Cardiovasc Pharmacol (1985) 1.49
Milbemycins, a new family of macrolide antibiotics: fermentation, isolation and physico-chemical properties. J Antibiot (Tokyo) (1980) 1.23
Isolation and characterization of thermostable chitinases from Bacillus licheniformis X-7u. Biochim Biophys Acta (1991) 1.15
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Attached Growth of Sphaerotilus natans in Continuous-Flow Apparatus and Its Growth Inhibition by 9-beta-d-Arabinofuranosyladenine. Appl Environ Microbiol (1979) 1.10
Purification of 3beta-hydroxysteroid oxidase of Streptomyces violascens origin by affinity chromatography on cholesterol. Chem Pharm Bull (Tokyo) (1978) 1.08
Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. FEBS Lett (1991) 1.03
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med (2001) 1.02
Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers. Circ Res (1988) 1.02
Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine. J Cardiovasc Pharmacol (1982) 1.01
Effect of chitosan on renal function in patients with chronic renal failure. J Pharm Pharmacol (1997) 1.00
Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest (1998) 1.00
MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma. Br J Cancer (2013) 0.99
Serum lipids and their relationships with hostility and angry affect and behaviors in men. Health Psychol (2000) 0.99
Trapping and intramyocardial distribution of microspheres with different diameters in cat and rabbit hearts in vitro. Basic Res Cardiol (1982) 0.99
Identification of a novel class of elastase isozyme, human pancreatic elastase III, by cDNA and genomic gene cloning. J Biol Chem (1988) 0.98
Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer. Br J Cancer (2003) 0.94
Implantation of ultraflex nitinol stents in malignant tracheobronchial stenoses. Chest (2000) 0.93
Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392. Eur J Pharmacol (1984) 0.93
Characterization of pancreatic elastase II cDNAs: two elastase II mRNAs are expressed in human pancreas. DNA (1987) 0.92
Mechanism of the vasodilator effects of the cardiotonic agent DPI 201-106. J Cardiovasc Pharmacol (1986) 0.92
Genomic organization of the human homologue of the rat pancreatic elastase I gene. DNA Seq (1992) 0.92
Phase I clinical studies of 7432-S, a new oral cephalosporin: safety and pharmacokinetics. J Clin Pharmacol (1988) 0.91
Characterization of a silent gene for human pancreatic elastase I: structure of the 5'-flanking region. J Biochem (1987) 0.91
Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed. Cancer Gene Ther (2012) 0.90
Herbicidins F and G, two new nucleoside antibiotics. J Antibiot (Tokyo) (1979) 0.90
Nucleotide sequence of the human pancreatic trypsinogen III cDNA. Nucleic Acids Res (1990) 0.90
Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator. Br J Pharmacol (1992) 0.90
Herbicidins C and E, two new necleoside antibiotics. J Antibiot (Tokyo) (1979) 0.89
Effects of hCGRP I and II on gastric blood flow and acid secretion in anesthetized rabbits. Am J Physiol (1989) 0.89
New antibiotics, methylenomycins A and B. I. Producing organism, fermentation and isolation, biological activities and physical and chemical properties. J Antibiot (Tokyo) (1974) 0.89
Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer. Br J Cancer (2000) 0.88
Stereoselectivity at the calcium channel: different profiles of hemodynamic activity of the enantiomers of the dihydropyridine derivative PN 200-110. J Cardiovasc Pharmacol (1986) 0.86
Differential effects of antihypertensive drugs on nutritive and nonnutritive blood flow in anaesthetized rabbits. J Cardiovasc Pharmacol (1989) 0.86
Very small microspheres are useful for the determination of cardiac output but not organ blood flow in conscious rabbits. Experientia (1981) 0.85
Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol (2002) 0.85
Characterization of the primate-specific repetitive DNA element MER1. DNA Seq (1992) 0.85
Acceleration of blood in the aorta: a parameter useful for evaluating cardiotonic and afterload reducing substances. J Pharmacol Methods (1981) 0.85
[A case of "thoracolithiasis"--an unusual isolated calcified lesion in the intrathoracic space]. Nihon Kyobu Shikkan Gakkai Zasshi (1987) 0.84
Milbemycins, a new family of macrolide antibiotics. Fermentation, isolation and physico-chemical properties of milbemycins D, E, F, G, and H. J Antibiot (Tokyo) (1983) 0.84
A simple cutter for fresh tissue to facilitate the investigation of intramyocardial blood flow with tracer microspheres in cats and rabbits. J Pharmacol Methods (1982) 0.83
Milbemycins, a new family of macrolide antibiotics. Studies on the biosynthesis of milbemycins alpha 2, alpha 4 and D using 13C labeled precursors. J Antibiot (Tokyo) (1983) 0.83
Comparison of the promoters of the mouse (APEX) and human (APE) apurinic endonuclease genes. Mutat Res (1997) 0.83
The effects of FasL on inflammation and tumor survival are dependent on its expression levels. Cancer Gene Ther (2006) 0.82
Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects. Eur J Clin Pharmacol (1988) 0.82
Effects of an aldose reductase inhibitor, ONO-2235, insulin and their combination on the altered responsiveness to the nerve stimulation and agonists of the isolated atria of diabetic rats. J Pharmacol Exp Ther (1990) 0.82
Effects of bromocriptine on the heart and the peripheral circulation of anesthetized cats. J Cardiovasc Pharmacol (1984) 0.81
Altered responsiveness to sympathetic nerve stimulation and agonists of isolated left atria of diabetic rats: no evidence for involvement of hypothyroidism. J Pharmacol Exp Ther (1989) 0.81
Massive regional differences in the vascular effects of endothelin. J Hypertens Suppl (1989) 0.80
Role of cell-mediated immune reaction in blister formation of bullous pemphigoid. Dermatology (1992) 0.80
GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure. J Med Chem (1998) 0.80
Phase I study of cefixime, a new oral cephalosporin. J Clin Pharmacol (1988) 0.80
Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts. Scand J Immunol (2004) 0.80
Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Transpl Immunol (2001) 0.80
Milbemycins, a new family of macrolide antibiotics. Fermentation, isolation, physico-chemical properties and bioconversion of milbemycins J and K. J Antibiot (Tokyo) (1983) 0.79
Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats. J Pharm Pharmacol (2001) 0.79
Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery. Thromb Haemost (1998) 0.79
Effect of arachidonic acid on the inner ear blood flow measured with a laser Doppler flowmeter. Ann Otol Rhinol Laryngol (1990) 0.79
Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation (2000) 0.79
[Mitotic activity of cancer cells and survival of gastric cancer patients]. Nihon Geka Gakkai Zasshi (1986) 0.79
Hemodynamic effects on aortic enzyme activities in spontaneously hypertensive rats. Atherosclerosis (1980) 0.79
Phase I study of Y-20811, a new long-acting thromboxane synthetase inhibitor by oral administration. J Clin Pharmacol (1989) 0.79
Biodegradation of triazine herbicides on polyvinylalcohol gel plates by the soil yeast Lipomyces starkeyi. Appl Microbiol Biotechnol (2002) 0.79
Baroreflex and atrial natriuretic factor concentration correlate with myocardial infarct size and predict early death in rabbits: implications for drug studies. J Cardiovasc Pharmacol (1991) 0.79
Reciprocal potentiation of a vasoconstrictor response between 5-hydroxytryptamine and clonidine in the perfused mesenteric vascular bed of the rat. Arch Int Pharmacodyn Ther (1987) 0.78
Extrinsic innervation of the canine superior vena cava, pulmonary, portal and renal veins. Angiology (1984) 0.78
The renin-angiotensin system modulates the peripheral vascular effects of the calcium antagonist isradipine in anesthetized rabbits. J Cardiovasc Pharmacol (1988) 0.78
Cell division patterns in the apices of subterranean axis and aerial shoot of Psilotum nudum (Psilotaceae): morphological and phylogenetic implications for the subterranean axis. Am J Bot (1997) 0.78
Antiarrhythmic and hemodynamic effects of tropisetron in anesthetized rabbits. J Cardiovasc Pharmacol (1993) 0.78
The glutamate receptor agonist, AMPA, induces acetylcholine release in guinea pig cochlea; a microdialysis study. Neurosci Lett (2001) 0.78
Diabetic ketoacidosis associated with recurrent pulmonary edema and rhabdomyolysis in a patient with Turner's syndrome. Intern Med (2001) 0.78
Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model. Transplantation (2001) 0.77
PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation. Basic Res Cardiol (1985) 0.77
Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol. Eur J Clin Pharmacol (1985) 0.77
Feasibility of cytological diagnosis of sarcoidosis with endobronchial US-guided transbronchial aspiration. Sarcoidosis Vasc Diffuse Lung Dis (2012) 0.77
Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig. Eur J Pharmacol (1993) 0.77
Recovery process of low-frequency fluctuations in laser diodes with external optical feedback. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.77
Adipogenesis inhibitory factor. A novel inhibitory regulator of adipose conversion in bone marrow. FEBS Lett (1991) 0.77
The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol (2000) 0.77
Proarrhythmic effects of DPI 201-106 elicited with programmed electrical stimulation: a comparison with sotalol. J Cardiovasc Pharmacol (1993) 0.77
Changes in Platelet Aggregation in Whole Blood, Plasma and Washed Platelets in Streptozotocin-induced Diabetic Rats: Time-dependent Change in the Antiaggregatory Activity of Diabetic Rat Plasma. Platelets (1993) 0.77
Vasoconstrictor and vasodilator effects in normal and atherosclerotic conscious rabbits. Br J Pharmacol (1988) 0.77
Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells. J Dermatol Sci (1990) 0.76
Effects of lithium on the pharmacokinetics of valproate in rats. J Pharm Pharmacol (2000) 0.76
Antivasoconstrictor effects of isradipine. A quantitative approach in anesthetized rats and conscious rabbits. Am J Med (1989) 0.76
A new carbapenam No. 17927 D substance. J Antibiot (Tokyo) (1983) 0.76
Dynamic effect of weak localization on the light scattering from random media using ultrafast laser technology. Appl Opt (1989) 0.76
Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects. Antimicrob Agents Chemother (1998) 0.76
Synergistic effect of combining theophylline and drugs that potentially elevate serum creatine kinase. J Med Invest (2000) 0.76
Estrogen markedly increases LDL-receptor activity in hypercholesterolemic patients. J Med (2000) 0.76
Interleukin-11: a novel stroma-derived cytokine. Prog Growth Factor Res (1992) 0.76
Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist. Bioorg Med Chem (1998) 0.75
Hemodynamic, antivasoconstrictor, and antiatherosclerotic effects of calcium antagonists in animal models of atherosclerosis. J Cardiovasc Pharmacol (1990) 0.75
[A clinicopathological study on hematogenous recurrence of colo-rectal cancer--with special reference to prediction and prevention of the recurrence]. Nihon Geka Gakkai Zasshi (1984) 0.75
Terminal steps in the biosynthesis of herbicidins, nucleoside antibiotics. J Antibiot (Tokyo) (1983) 0.75